NLS Pharmaceutics AG

1.78
-0.06 (-3.26%)
At close: Mar 03, 2025, 3:59 PM
1.77
-0.56%
After-hours: Mar 03, 2025, 05:14 PM EST

NLS Pharmaceutics AG Statistics

Share Statistics

NLS Pharmaceutics AG has 2.47M shares outstanding. The number of shares has increased by -93.07% in one year.

Shares Outstanding 2.47M
Shares Change (YoY) -93.07%
Shares Change (QoQ) 110.96%
Owned by Institutions (%) 22.34%
Shares Floating 1.57M
Failed to Deliver (FTD) Shares 6.39K
FTD / Avg. Volume 0.22%

Short Selling Information

The latest short interest is 85.78K, so 3.47% of the outstanding shares have been sold short.

Short Interest 85.78K
Short % of Shares Out 3.47%
Short % of Float 5.26%
Short Ratio (days to cover) 0.04

Valuation Ratios

The PE ratio is -73.77 and the forward PE ratio is -3.42. NLS Pharmaceutics AG's PEG ratio is 1.19.

PE Ratio -73.77
Forward PE -3.42
PS Ratio 0
Forward PS 0
PB Ratio -101.65
P/FCF Ratio -92.72
PEG Ratio 1.19
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for NLS Pharmaceutics AG.

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.23, with a Debt / Equity ratio of -0.18.

Current Ratio 0.23
Quick Ratio 0.23
Debt / Equity -0.18
Total Debt / Capitalization -22.69
Cash Flow / Debt -5.93
Interest Coverage -81.34

Financial Efficiency

Return on equity (ROE) is 1.38% and return on capital (ROIC) is 163.99%.

Return on Equity (ROE) 1.38%
Return on Assets (ROA) -6.59%
Return on Capital (ROIC) 163.99%
Revenue Per Employee $0
Profits Per Employee $-2,028,671.5
Employee Count 6
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -87.29% in the last 52 weeks. The beta is -0.3, so NLS Pharmaceutics AG's price volatility has been lower than the market average.

Beta -0.3
52-Week Price Change -87.29%
50-Day Moving Average 2.05
200-Day Moving Average 4.8
Relative Strength Index (RSI) 40.06
Average Volume (20 Days) 2.97M

Income Statement

Revenue n/a
Gross Profit -11.41K
Operating Income -11.81M
Net Income -12.17M
EBITDA -11.8M
EBIT n/a
Earnings Per Share (EPS) -0.32
Full Income Statement

Balance Sheet

The company has 897.68K in cash and 1.63M in debt, giving a net cash position of -736.07K.

Cash & Cash Equivalents 897.68K
Total Debt 1.63M
Net Cash -736.07K
Retained Earnings -70.37M
Total Assets 1.19M
Working Capital -6.53M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.68M and capital expenditures -4, giving a free cash flow of -9.68M.

Operating Cash Flow -9.68M
Capital Expenditures -4
Free Cash Flow -9.68M
FCF Per Share -0.25
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NLSP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -17.98%
FCF Yield -220.05%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for NLSP.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Sep 27, 2024. It was a backward split with a ratio of 1:40.

Last Split Date Sep 27, 2024
Split Type backward
Split Ratio 1:40

Scores

Altman Z-Score -148.49
Piotroski F-Score 1